An employee monitors a vial making machine inside a manufacturing unit of Schott Kaisha, India's largest vial manufacturer, in Daman, India, December 2, 2020. Picture taken December 2, 2020. REUTERS/Francis Mascarenhas
PUNE, India/NEW DELHI (Reuters) - India, the world's biggest vaccine maker, is getting set for the massive global blitz to contain the coronavirus pandemic with its pharmaceutical industry and partners freeing up capacity and accelerating investments even without firm purchase orders.
India manufactures more than 60% of all vaccines sold across the globe, and while its $40 billion pharmaceutical sector is not yet involved in the production of the expensive Pfizer Inc and Moderna shots, the nation will play a pivotal role in immunizing much of the world.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
